SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-12-029338
Filing Date
2012-04-27
Accepted
2012-04-27 07:02:39
Documents
5
Effectiveness Date
2012-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A a12-1647_3defa14a.htm DEFA14A 62531
2 GRAPHIC g16473bci001.gif GRAPHIC 83025
3 GRAPHIC g16473bci002.gif GRAPHIC 91405
4 GRAPHIC g16473bci003.gif GRAPHIC 42506
5 GRAPHIC g16473bci004.gif GRAPHIC 38698
  Complete submission text file 0001104659-12-029338.txt   416333
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32966 | Film No.: 12785416
SIC: 2836 Biological Products, (No Diagnostic Substances)